Impact of coronary flow reserve as an important predictor for major adverse cardiac and cerebrovascular event in hemodialysis patients even in patients without myocardial perfusion abnormality.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Norio Umemoto

Ichinomiya municipal hospital, Ichinomiya (Japan)

18 More presentations in this session

Presentation thumbnail

Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy.

Associate Professor P. Rainer (St Johann in Tirol, AT)

Abstract Slides

Presentation thumbnail

International cardiovascular disease risk calculators do not identify high risk in young hodgkin lymphoma survivors

Doctor K. Piddock (Manchester, GB)

Presentation thumbnail

Late adverse effects of residual platinum concentrations on cardiac function in testicular cancer survivors: a 30-year follow-up study

Doctor A. Bjerring (Oslo, NO)

Abstract Slides

Presentation thumbnail

The impact of stress myocardial blood flow as a very strong predictor for all-cause mortality, cardiovascular mortality and adverse cardiac and cerebrovascular event in hemodialysis population.

Doctor S. Ooshima (Nagoya, JP)

Presentation thumbnail

Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention

Doctor S. Okuno (Amagasaki, JP)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous

The Event

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources